QIAGEN GmbH

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Operator of a genetic testing laboratory dedicated to providing accurate results. The company offers consumer and legal DNA testing services for paternity and family relationships, fertility, lifestyle, veterinary and forensics using automated precision instrumentations, enabling consumers, government agencies, legal professionals and healthcare practitioners to obtain quick results and answers in a private manner that is affordable.

Developer of animal vaccination and diagnostic kits and provider of diagnostic services dedicated to becoming the reference in prevention for animal health. The company's product offering includes vaccination for swine, poultry, cattle, sheep, goats, rabbits, and more, needle-free injection devices, diagnostic kits, vaccination spray devices, smart vaccination devices that use RFID technology to ensure precision and efficiency, and more, it has developed a tool that captures optical densities from an ELISA reader and interprets the results in a chart, it also provides laboratory testing, animal health consulting services and training programs in the field of disease prevention,more